Literature DB >> 8910454

Isolation and characterization of the human cytochrome P450 CYP1B1 gene.

Y M Tang1, Y Y Wo, J Stewart, A L Hawkins, C A Griffin, T R Sutter, W F Greenlee.   

Abstract

Previously, we identified a novel human cytochrome P450 cDNA that is inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and represents the first member of a new subfamily designated cytochrome P4501B1 (CYP1B1; Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. (1994) J. Biol. Chem. 269, 13092-13099). Here, we report on the isolation and initial characterization of the CYP1B1 gene. The CYP1B1 gene maps to human chromosome 2 at 2p21-22 and contains three exons and two introns. The putative open reading frame starts in the second exon and is 1629 base pairs in length. Southern analysis using DNA probes directed to each of the three exons confirmed that CYP1B1 is a single copy gene. Human CYP1B1 differs from its two most closely related members of the cytochrome P450 superfamily, CYP1A1 and CYP1A2, in the number of exons (3 versus 7) and chromosome location (2 versus 15). A single transcription initiation site was identified by primer extension analysis and S1 nuclease mapping. Based on nucleotide sequence analysis, the CYP1B1 gene lacks a consensus TATA box in the promoter region and contains nine TCDD-responsive enhancer core binding motifs (5'-GCGTG-3') located within a 2.5-kilobase pair genomic fragment 5'-ward of the transcription initiation start site. Deletion analysis of chloramphenicol acetyltransferase reporter gene constructs containing 5' CYP1B1 genomic fragments indicates that a region from -1022 to -835 containing three of the nine core binding motifs contributes to the TCDD-inducible expression of CYP1B1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910454     DOI: 10.1074/jbc.271.45.28324

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma.

Authors:  M Plásilová; I Stoilov; M Sarfarazi; L Kádasi; E Feráková; V Ferák
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Authors:  Inik Chang; Shinichiro Fukuhara; Darryn K Wong; Ankurpreet Gill; Yozo Mitsui; Shahana Majid; Sharanjot Saini; Soichiro Yamamura; Takeshi Chiyomaru; Hiroshi Hirata; Koji Ueno; Sumit Arora; Varahram Shahryari; Guoren Deng; Z Laura Tabatabai; Kirsten L Greene; Dong Min Shin; Hideki Enokida; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Tumour Biol       Date:  2014-07-17

3.  Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia.

Authors:  B A Bejjani; R A Lewis; K F Tomey; K L Anderson; D K Dueker; M Jabak; W F Astle; B Otterud; M Leppert; J R Lupski
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 4.  Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.

Authors:  Kafait U Malik; Brett L Jennings; Fariborz A Yaghini; Seyhan Sahan-Firat; Chi Young Song; Anne M Estes; Xiao R Fang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-20       Impact factor: 3.072

5.  Genetic variation in the CYP1A1 gene is related to circulating PCB118 levels in a population-based sample.

Authors:  Lars Lind; Johanna Penell; Anne-Christine Syvänen; Tomas Axelsson; Erik Ingelsson; Andrew P Morris; Cecilia Lindgren; Samira Salihovic; Bert van Bavel; P Monica Lind
Journal:  Environ Res       Date:  2014-06-11       Impact factor: 6.498

6.  Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.

Authors:  Yifan Huang; Amy Trentham-Dietz; Montserrat García-Closas; Polly A Newcomb; Linda Titus-Ernstoff; John M Hampton; Stephen J Chanock; Jonathan L Haines; Kathleen M Egan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

7.  Stimulation of mouse Cyp1b1 during adipogenesis: characterization of promoter activation by the transcription factor Pax6.

Authors:  Wenchao Zheng; Tiegang Tong; Jinwoo Lee; Xueqing Liu; Craig Marcus; Colin R Jefcoate
Journal:  Arch Biochem Biophys       Date:  2013-01-29       Impact factor: 4.013

Review 8.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

9.  Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.

Authors:  Erin P Madeen; Christiane V Löhr; Hannah You; Lisbeth K Siddens; Sharon K Krueger; Roderick H Dashwood; Frank J Gonzalez; William M Baird; Emily Ho; Lisa Bramer; Katrina M Waters; David E Williams
Journal:  Mol Carcinog       Date:  2016-03-17       Impact factor: 4.784

10.  Cytochrome P450 1B1 mRNA in the human central nervous system.

Authors:  C R Rieder; D B Ramsden; A C Williams
Journal:  Mol Pathol       Date:  1998-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.